: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

Oliena Studio

Stroke and language recovery: 9000+ videos

Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription

Articles published in PLoS One
Retrieve available abstracts of 359 articles:
HTML format
Text format

Single Articles

January 2019

OH DK, Ji WJ, Kim WS, Choi CM, et al
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice.
PLoS One. 2019;14:e0210225.
PubMed Text format Abstract available

CHOUAID C, Salaun M, Gounant V, Febvre M, et al
Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a French prospective multicenter trial (EVIEPEB).
PLoS One. 2019;14:e0208992.
PubMed Text format Abstract available

LI Y, Appius A, Pattipaka T, Feyereislova A, et al
Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.
PLoS One. 2019;14:e0209709.
PubMed Text format Abstract available

SUKIENNICKI GM, Marciniak W, Muszynska M, Baszuk P, et al
Iron levels, genes involved in iron metabolism and antioxidative processes and lung cancer incidence.
PLoS One. 2019;14:e0208610.
PubMed Text format Abstract available

NISHIO M, Kubo T, Togashi K
Estimation of lung cancer risk using homology-based emphysema quantification in patients with lung nodules.
PLoS One. 2019;14:e0210720.
PubMed Text format Abstract available

AGEMI Y, Shimokawa T, Sasaki J, Miyazaki K, et al
Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.
PLoS One. 2019;14:e0210499.
PubMed Text format Abstract available

KIM Y, Lee D, Lee J, Lee S, et al
Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model.
PLoS One. 2019;14:e0211041.
PubMed Text format Abstract available

MUENCH D, Rezzoug F, Thomas SD, Xiao J, et al
Quadruplex-forming oligonucleotide targeted to the VEGF promoter inhibits growth of non-small cell lung cancer cells.
PLoS One. 2019;14:e0211046.
PubMed Text format Abstract available

CHO YJ, Kim WS, Choi YH, Ha JY, et al
Computerized texture analysis of pulmonary nodules in pediatric patients with osteosarcoma: Differentiation of pulmonary metastases from non-metastatic nodules.
PLoS One. 2019;14:e0211969.
PubMed Text format Abstract available

KEMP JACOBSEN K, Johansen JS, Mellemgaard A, Bojesen SE, et al
AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival.
PLoS One. 2019;14:e0211745.
PubMed Text format Abstract available

PADAYACHEE T, Khamiakova T, Louis E, Adriaensens P, et al
The impact of the method of extracting metabolic signal from 1H-NMR data on the classification of samples: A case study of binning and BATMAN in lung cancer.
PLoS One. 2019;14:e0211854.
PubMed Text format Abstract available

SONG JH, Kim S, Lee HW, Lee YJ, et al
Effect of intensivist involvement on clinical outcomes in patients with advanced lung cancer admitted to the intensive care unit.
PLoS One. 2019;14:e0210951.
PubMed Text format Abstract available

FU JY, Wan YL, Huang TY, Wu CF, et al
Correction: Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection.
PLoS One. 2019;14:e0212461.
PubMed Text format Abstract available

JEON SM, Kwon JW, Choi SH, Park HY, et al
Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015.
PLoS One. 2019;14:e0212878.
PubMed Text format Abstract available

MAGUIRE FB, Morris CR, Parikh-Patel A, Cress RD, et al
A text-mining approach to obtain detailed treatment information from free-text fields in population-based cancer registries: A study of non-small cell lung cancer in California.
PLoS One. 2019;14:e0212454.
PubMed Text format Abstract available

SCHREUDER A, Jacobs C, Gallardo-Estrella L, Prokop M, et al
Predicting all-cause and lung cancer mortality using emphysema score progression rate between baseline and follow-up chest CT images: A comparison of risk model performances.
PLoS One. 2019;14:e0212756.
PubMed Text format Abstract available

LI Y, Appius A, Pattipaka T, Feyereislova A, et al
Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA.
PLoS One. 2019;14:e0212831.
PubMed Text format Abstract available

SISSUNG TM, Rajan A, Blumenthal GM, Liewehr DJ, et al
Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer.
PLoS One. 2019;14:e0212097.
PubMed Text format Abstract available

GUO X, Liu Y, Kim JL, Kim EY, et al
Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the KrasG12D+; p53fl/fl; myristolated p110fl/fl ROSA-gfp mouse.
PLoS One. 2019;14:e0212930.
PubMed Text format Abstract available

UNRINE JM, Slone SA, Sanderson W, Johnson N, et al
A case-control study of trace-element status and lung cancer in Appalachian Kentucky.
PLoS One. 2019;14:e0212340.
PubMed Text format Abstract available

CHOI YJ, Park GM, Rho JK, Kim SY, et al
Correction: Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors.
PLoS One. 2019;14:e0213984.
PubMed Text format Abstract available

Expression of Concern: Autophagosome-Mediated EGFR Down-Regulation Induced by the CK2 Inhibitor Enhances the Efficacy of EGFR-TKI on EGFR-Mutant Lung Cancer Cells with Resistance by T790M.
PLoS One. 2019;14:e0213989.
PubMed Text format

STANISLAWSKA-SACHADYN A, Borzyszkowska J, Krzeminski M, Janowicz A, et al
Folate/homocysteine metabolism and lung cancer risk among smokers.
PLoS One. 2019;14:e0214462.
PubMed Text format Abstract available

GERMONPRE P, Van den Wyngaert T
Second-line erlotinib after failure of pemetrexed-containing chemotherapy in advanced non-small cell lung cancer (NSCLC): Real-world effectiveness, safety and tolerability.
PLoS One. 2019;14:e0215135.
PubMed Text format Abstract available

ZABLOCKA-SLOWINSKA K, Placzkowska S, Skorska K, Prescha A, et al
Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism.
PLoS One. 2019;14:e0215246.
PubMed Text format Abstract available

O'FLAHERTY L, Shnyder SD, Cooper PA, Cross SJ, et al
Tumor growth suppression using a combination of taxol-based therapy and GSK3 inhibition in non-small cell lung cancer.
PLoS One. 2019;14:e0214610.
PubMed Text format Abstract available

SHIRASAWA M, Fukui T, Kusuhara S, Harada S, et al
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
PLoS One. 2019;14:e0214599.
PubMed Text format Abstract available

DUNCAN DJ, Scott M, Scorer P, Barker C, et al
Assessment of PD-L1 mRNA and protein expression in non-small cell lung cancer, head and neck squamous cell carcinoma and urothelial carcinoma tissue specimens using RNAScope and immunohistochemistry.
PLoS One. 2019;14:e0215393.
PubMed Text format Abstract available

YUN PJ, Wang GC, Chen YY, Wu TH, et al
Brain metastases in resected non-small cell lung cancer: The impact of different tyrosine kinase inhibitors.
PLoS One. 2019;14:e0215923.
PubMed Text format Abstract available

HU ZG, Hu K, Li WX, Zeng FJ, et al
Prognostic factors and nomogram for cancer-specific death in non small cell lung cancer with malignant pericardial effusion.
PLoS One. 2019;14:e0217007.
PubMed Text format Abstract available

STANZE H, Schneider N, Nauck F, Marx G, et al
"I can't get it into my head that I have cancer..."-A qualitative interview study on needs of patients with lung cancer.
PLoS One. 2019;14:e0216778.
PubMed Text format Abstract available

SUZUKI A, Puri S, Leland P, Puri A, et al
Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
PLoS One. 2019;14:e0217131.
PubMed Text format Abstract available

THEELEN WSME, Kuilman T, Schulze K, Zou W, et al
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNgamma signaling in non-small cell lung cancer.
PLoS One. 2019;14:e0216864.
PubMed Text format Abstract available

LIU J, Liu S, Deng X, Rao J, et al
MicroRNA-582-5p suppresses non-small cell lung cancer cells growth and invasion via downregulating NOTCH1.
PLoS One. 2019;14:e0217652.
PubMed Text format Abstract available

NAKAMURA H, Fujii K, Gupta V, Hata H, et al
Identification of key modules and hub genes for small-cell lung carcinoma and large-cell neuroendocrine lung carcinoma by weighted gene co-expression network analysis of clinical tissue-proteomes.
PLoS One. 2019;14:e0217105.
PubMed Text format Abstract available

RICE SJ, Liu X, Wang HG, Belani CP, et al
EGFR mutations and AKT phosphorylation are markers for sensitivity to combined MCL-1 and BCL-2/xL inhibition in non-small cell lung cancer.
PLoS One. 2019;14:e0217657.
PubMed Text format Abstract available

BYCHKOV M, Shenkarev Z, Shulepko M, Shlepova O, et al
Water-soluble variant of human Lynx1 induces cell cycle arrest and apoptosis in lung cancer cells via modulation of alpha7 nicotinic acetylcholine receptors.
PLoS One. 2019;14:e0217339.
PubMed Text format Abstract available

WALTER J, Tufman A, Holle R, Schwarzkopf L, et al
"Age matters"-German claims data indicate disparities in lung cancer care between elderly and young patients.
PLoS One. 2019;14:e0217434.
PubMed Text format Abstract available

NAM MW, Kim JM, Cheong JH, Ryu JI, et al
Paradoxical relationship between body mass index and bone mineral density in patients with non-small cell lung cancer with brain metastasis.
PLoS One. 2019;14:e0218825.
PubMed Text format Abstract available

BEHRENDT CE, Cosgrove CM, Johnson NJ, Altekruse SF, et al
Are associations between psychosocial stressors and incident lung cancer attributable to smoking?
PLoS One. 2019;14:e0218439.
PubMed Text format Abstract available

LEE CC, Soon YY, Tan CL, Koh WY, et al
Discordance of epidermal growth factor receptor mutation between primary lung tumor and paired distant metastases in non-small cell lung cancer: A systematic review and meta-analysis.
PLoS One. 2019;14:e0218414.
PubMed Text format Abstract available

ALCANTUD JCR, Varela G, Santos-Buitrago B, Santos-Garcia G, et al
Analysis of survival for lung cancer resections cases with fuzzy and soft set theory in surgical decision making.
PLoS One. 2019;14:e0218283.
PubMed Text format Abstract available

RADKIEWICZ C, Dickman PW, Johansson ALV, Wagenius G, et al
Sex and survival in non-small cell lung cancer: A nationwide cohort study.
PLoS One. 2019;14:e0219206.
PubMed Text format Abstract available

DACOSTA-NOBLE P, Costantini A, Dumenil C, Dumoulin J, et al
Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.
PLoS One. 2019;14:e0219080.
PubMed Text format Abstract available

POVSIC M, Enstone A, Wyn R, Kornalska K, et al
Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR).
PLoS One. 2019;14:e0219622.
PubMed Text format Abstract available

GONZALEZ J, Henschke CI, Yankelevitz DF, Seijo LM, et al
Emphysema phenotypes and lung cancer risk.
PLoS One. 2019;14:e0219187.
PubMed Text format Abstract available

WEI T, Zhu D, Yang Y, Yuan G, et al
The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment.
PLoS One. 2019;14:e0219129.
PubMed Text format Abstract available

CAMERLINGO R, Miceli R, Marra L, Rea G, et al
Conditioned medium of primary lung cancer cells induces EMT in A549 lung cancer cell line by TGF-ss1 and miRNA21 cooperation.
PLoS One. 2019;14:e0219597.
PubMed Text format Abstract available

TOPKAN E, Ozdemir Y, Kucuk A, Besen AA, et al
Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients.
PLoS One. 2019;14:e0218627.
PubMed Text format Abstract available

LUNG J, Hung MS, Lin YC, Lee KF, et al
MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population.
PLoS One. 2019;14:e0220670.
PubMed Text format Abstract available

EDAHIRO R, Kanazu M, Kurebe H, Mori M, et al
Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 treated using pembrolizumab as a first-line therapy: A retrospective multicenter cohort study in Japan.
PLoS One. 2019;14:e0220570.
PubMed Text format Abstract available

CHEN Y, Watson TR, Criss SD, Eckel A, et al
A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea.
PLoS One. 2019;14:e0220610.
PubMed Text format Abstract available

DONG J, Zhu D, Tang X, Lu D, et al
Circulating tumor cells in pulmonary vein and peripheral arterial provide a metric for PD-L1 diagnosis and prognosis of patients with non-small cell lung cancer.
PLoS One. 2019;14:e0220306.
PubMed Text format Abstract available

PIPER AJ, Clark JL, Mercado-Matos J, Matthew-Onabanjo AN, et al
Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
PLoS One. 2019;14:e0220567.
PubMed Text format Abstract available

KOYAMA N, Iwai Y, Nagai Y, Aoshiba K, et al
Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
PLoS One. 2019;14:e0221718.
PubMed Text format Abstract available

PUJOL JL, Coffy A, Camerini A, Kotsakis A, et al
An individual patient-data meta-analysis of metronomic oral vinorelbine in metastatic non-small cell lung cancer.
PLoS One. 2019;14:e0220988.
PubMed Text format Abstract available

YU S, Choi HH, Kim IW, Kim TJ, et al
Conditioned medium from asbestos-exposed fibroblasts affects proliferation and invasion of lung cancer cell lines.
PLoS One. 2019;14:e0222160.
PubMed Text format Abstract available

PAIK SH, Yeo CD, Jeong JE, Kim JS, et al
Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer.
PLoS One. 2019;14:e0220127.
PubMed Text format Abstract available

KUNIMASA K, Kato K, Imamura F, Kukita Y, et al
Quantitative detection of ALK fusion breakpoints in plasma cell-free DNA from patients with non-small cell lung cancer using PCR-based target sequencing with a tiling primer set and two-step mapping/alignment.
PLoS One. 2019;14:e0222233.
PubMed Text format Abstract available

CHILET-ROSELL E, Parker LA, Hernandez-Aguado I, Pastor-Valero M, et al
The determinants of lung cancer after detecting a solitary pulmonary nodule are different in men and women, for both chest radiograph and CT.
PLoS One. 2019;14:e0221134.
PubMed Text format Abstract available

BANSAL M, He J, Peyton M, Kustagi M, et al
Elucidating synergistic dependencies in lung adenocarcinoma by proteome-wide signaling-network analysis.
PLoS One. 2019;14:e0208646.
PubMed Text format Abstract available

HU HP, Chan H, Ujiie H, Bernards N, et al
Nanoparticle-based CT visualization of pulmonary vasculature for minimally-invasive thoracic surgery planning.
PLoS One. 2019;14:e0209501.
PubMed Text format Abstract available

ZHANG H, Chen J, Liu T, Dang J, et al
First-line treatments in EGFR-mutated advanced non-small cell lung cancer: A network meta-analysis.
PLoS One. 2019;14:e0223530.
PubMed Text format Abstract available

HUA X, Han SH, Wei SZ, Wu Y, et al
Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis.
PLoS One. 2019;14:e0223230.
PubMed Text format Abstract available

SHAO B, Bjaanaes MM, Helland A, Schutte C, et al
EMT network-based feature selection improves prognosis prediction in lung adenocarcinoma.
PLoS One. 2019;14:e0204186.
PubMed Text format Abstract available

MITSUYA K, Nakasu Y, Hayashi N, Deguchi S, et al
Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
PLoS One. 2019;14:e0210074.
PubMed Text format Abstract available

LU S, Dong Z
Additive effects of a small molecular PCNA inhibitor PCNA-I1S and DNA damaging agents on growth inhibition and DNA damage in prostate and lung cancer cells.
PLoS One. 2019;14:e0223894.
PubMed Text format Abstract available

CIERESZKO A, Dietrich MA, Slowinska M, Nynca J, et al
Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach.
PLoS One. 2019;14:e0223840.
PubMed Text format Abstract available

DUNCAN DJ, Vandenberghe ME, Scott MLJ, Barker C, et al
Fast fluorescence in situ hybridisation for the enhanced detection of MET in non-small cell lung cancer.
PLoS One. 2019;14:e0223926.
PubMed Text format Abstract available

ZHANG P, He D, Song E, Jiang M, et al
Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression.
PLoS One. 2019;14:e0223760.
PubMed Text format Abstract available

GANEM J, Thureau S, Gouel P, Dubray B, et al
Prognostic value of post-induction chemotherapy 18F-FDG PET-CT in stage II/III non-small cell lung cancer before (chemo-) radiation.
PLoS One. 2019;14:e0222885.
PubMed Text format Abstract available

January 2018

CHEN WC, Su VY, Yu WK, Chen YW, et al
Prognostic factors of noninvasive mechanical ventilation in lung cancer patients with acute respiratory failure.
PLoS One. 2018;13:e0191204.
PubMed Text format Abstract available

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
PLoS One. 2018;13:e0191454.
PubMed Text format Abstract available

CHUANG MC, Yang YH, Tsai YH, Hsieh MJ, et al
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
PLoS One. 2018;13:e0191129.
PubMed Text format Abstract available

BELQAID K, Tishelman C, Orrevall Y, Mansson-Brahme E, et al
Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer.
PLoS One. 2018;13:e0191117.
PubMed Text format Abstract available

PARK S, Ha S, Lee SH, Paeng JC, et al
Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
PLoS One. 2018;13:e0189766.
PubMed Text format Abstract available

SHIN DW, Chun S, Kim YI, Kim SJ, et al
A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.
PLoS One. 2018;13:e0192626.
PubMed Text format Abstract available

KILVAER TK, Rakaee M, Hellevik T, Ostman A, et al
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
PLoS One. 2018;13:e0192157.
PubMed Text format Abstract available

KIRIU T, Yamamoto M, Nagano T, Hazama D, et al
The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer.
PLoS One. 2018;13:e0193018.
PubMed Text format Abstract available

HOVANEC J, Siemiatycki J, Conway DI, Olsson A, et al
Lung cancer and socioeconomic status in a pooled analysis of case-control studies.
PLoS One. 2018;13:e0192999.
PubMed Text format Abstract available

PAK K, Kim K, Kim MH, Eom JS, et al
A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
PLoS One. 2018;13:e0193403.
PubMed Text format Abstract available

TAMIYA M, Tamiya A, Inoue T, Kimura M, et al
Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.
PLoS One. 2018;13:e0192227.
PubMed Text format Abstract available

Correction: Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
PLoS One. 2018;13:e0194257.
PubMed Text format Abstract available

CARVALHO S, Leijenaar RTH, Troost EGC, van Timmeren JE, et al
18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
PLoS One. 2018;13:e0192859.
PubMed Text format Abstract available

MALEKI VAREKI S, Salim KY, Danter WR, Koropatnick J, et al
Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
PLoS One. 2018;13:e0191766.
PubMed Text format Abstract available

HAN Y, Kim HJ, Kong KA, Kim SJ, et al
Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis.
PLoS One. 2018;13:e0191590.
PubMed Text format Abstract available

ZHANG Z, Wang H, Ding Q, Xing Y, et al
Establishment of patient-derived tumor spheroids for non-small cell lung cancer.
PLoS One. 2018;13:e0194016.
PubMed Text format Abstract available

MIHOUB M, Pichette A, Sylla B, Gauthier C, et al
Bidesmosidic betulin saponin bearing L-rhamnopyranoside moieties induces apoptosis and inhibition of lung cancer cells growth in vitro and in vivo.
PLoS One. 2018;13:e0193386.
PubMed Text format Abstract available

BUHL IK, Santoni-Rugiu E, Ravn J, Hansen A, et al
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
PLoS One. 2018;13:e0194609.
PubMed Text format Abstract available

DEHUA Z, Mingming C, Jisheng W
Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.
PLoS One. 2018;13:e0193814.
PubMed Text format Abstract available

CHANG WY, Wu YL, Su PL, Yang SC, et al
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
PLoS One. 2018;13:e0192161.
PubMed Text format Abstract available

KIM CR, Kim EY, Kim YS, Ahn HK, et al
Histologic subtypes are not associated with the presence of sarcopenia in lung cancer.
PLoS One. 2018;13:e0194626.
PubMed Text format Abstract available

CHEN CH, Chang CK, Tu CY, Liao WC, et al
Radiomic features analysis in computed tomography images of lung nodule classification.
PLoS One. 2018;13:e0192002.
PubMed Text format Abstract available

FU M, Travier N, Martin-Sanchez JC, Martinez-Sanchez JM, et al
Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
PLoS One. 2018;13:e0195441.
PubMed Text format Abstract available

LEE EH, Park CH, Choi HJ, Kawala RA, et al
Dexamethasone modified by gamma-irradiation as a novel anticancer drug in human non-small cell lung cancer.
PLoS One. 2018;13:e0194341.
PubMed Text format Abstract available

ERNST AK, Putscher A, Samatov TR, Suling A, et al
Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
PLoS One. 2018;13:e0192525.
PubMed Text format Abstract available

LIU K, Zheng D, Xu G, Du Z, et al
Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
PLoS One. 2018;13:e0196618.
PubMed Text format Abstract available

BISAGNI A, Pagano M, Maramotti S, Zanelli F, et al
Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.
PLoS One. 2018;13:e0196350.
PubMed Text format Abstract available

CIRCU M, Cardelli J, Barr MP, O'Byrne K, et al
Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
PLoS One. 2018;13:e0197016.
PubMed Text format Abstract available

DEROUEN MC, Hu L, McKinley M, Gali K, et al
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California.
PLoS One. 2018;13:e0197146.
PubMed Text format Abstract available

EDELSBERG J, Weycker D, Atwood M, Hamilton-Fairley G, et al
Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
PLoS One. 2018;13:e0197826.
PubMed Text format Abstract available

KIM H, Kwon HJ, Park SY, Park Y, et al
Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer.
PLoS One. 2018;13:e0198634.
PubMed Text format Abstract available

ZHANG X, Nakajima T, Kim M, Yamaguchi A, et al
Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
PLoS One. 2018;13:e0198224.
PubMed Text format Abstract available

WALTER RFH, Rozynek P, Casjens S, Werner R, et al
Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
PLoS One. 2018;13:e0195716.
PubMed Text format Abstract available

KIM KI, Jun JH, Baek H, Kim JH, et al
Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis.
PLoS One. 2018;13:e0198015.
PubMed Text format Abstract available

GU L, Wang Z, Zuo J, Li H, et al
Prognostic significance of NF-kappaB expression in non-small cell lung cancer: A meta-analysis.
PLoS One. 2018;13:e0198223.
PubMed Text format Abstract available

CHORNER PM, Moorehead RA
A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206.
PLoS One. 2018;13:e0193344.
PubMed Text format Abstract available

SILVA MA, Ryall KA, Wilm C, Caldara J, et al
PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters.
PLoS One. 2018;13:e0196464.
PubMed Text format Abstract available

HSIEH LY, Chou FJ, Guo SE
Information needs of patients with lung cancer from diagnosis until first treatment follow-up.
PLoS One. 2018;13:e0199515.
PubMed Text format Abstract available

DANISH L, Imig D, Allgower F, Scheurich P, et al
Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps.
PLoS One. 2018;13:e0198203.
PubMed Text format Abstract available

BLUME JD, D'Agostino McGowan L, Dupont WD, Greevy RA Jr, et al
Second-generation p-values: Improved rigor, reproducibility, & transparency in statistical analyses.
PLoS One. 2018;13:e0188299.
PubMed Text format Abstract available

PLAGNOL V, Woodhouse S, Howarth K, Lensing S, et al
Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling.
PLoS One. 2018;13:e0193802.
PubMed Text format Abstract available

YANG M, Feng Y, Yue C, Xu B, et al
Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
PLoS One. 2018;13:e0193428.
PubMed Text format Abstract available

FERRARINI A, Forcato C, Buson G, Tononi P, et al
A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
PLoS One. 2018;13:e0193689.
PubMed Text format Abstract available

ROTH JA, Carter-Harris L, Brandzel S, Buist DSM, et al
A qualitative study exploring patient motivations for screening for lung cancer.
PLoS One. 2018;13:e0196758.
PubMed Text format Abstract available

HEIDEN BT, Chen G, Hermann M, Brown RKJ, et al
18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
PLoS One. 2018;13:e0199970.
PubMed Text format Abstract available

LIM JU, Yeo CD, Kang HS, Park CK, et al
Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.
PLoS One. 2018;13:e0200341.
PubMed Text format Abstract available

DUAN L, Ye L, Zhuang L, Zou X, et al
VEGFC/VEGFR3 axis mediates TGFbeta1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells.
PLoS One. 2018;13:e0200452.
PubMed Text format Abstract available

LU X, Gao J, Zhang Y, Zhao T, et al
CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells.
PLoS One. 2018;13:e0198823.
PubMed Text format Abstract available

PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
PLoS One. 2018;13:e0194790.
PubMed Text format Abstract available

YURCHENKO KS, Zhou P, Kovner AV, Zavjalov EL, et al
Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
PLoS One. 2018;13:e0195425.
PubMed Text format Abstract available

FATHI Z, Mousavi SAJ, Roudi R, Ghazi F, et al
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients.
PLoS One. 2018;13:e0200633.
PubMed Text format Abstract available

ARMOIRY X, Tsertsvadze A, Connock M, Royle P, et al
Comparative efficacy and safety of licensed treatments for previously treated non-small cell lung cancer: A systematic review and network meta-analysis.
PLoS One. 2018;13:e0199575.
PubMed Text format Abstract available

DUMENIL C, Massiani MA, Dumoulin J, Giraud V, et al
Clinical factors associated with early progression and grade 3-4 toxicity in patients with advanced non-small-cell lung cancers treated with nivolumab.
PLoS One. 2018;13:e0195945.
PubMed Text format Abstract available

NISHIO M, Nishizawa M, Sugiyama O, Kojima R, et al
Computer-aided diagnosis of lung nodule using gradient tree boosting and Bayesian optimization.
PLoS One. 2018;13:e0195875.
PubMed Text format Abstract available

KU BM, Choi MK, Sun JM, Lee SH, et al
Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model.
PLoS One. 2018;13:e0194730.
PubMed Text format Abstract available

JANSEN RJ, Alexander BH, Hayes RB, Miller AB, et al
A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
PLoS One. 2018;13:e0194608.
PubMed Text format Abstract available

NISHIO M, Sugiyama O, Yakami M, Ueno S, et al
Computer-aided diagnosis of lung nodule classification between benign nodule, primary lung cancer, and metastatic lung cancer at different image size using deep convolutional neural network with transfer learning.
PLoS One. 2018;13:e0200721.
PubMed Text format Abstract available

HIMES BE, Obraztsova K, Lian L, Shumyatcher M, et al
Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells.
PLoS One. 2018;13:e0197105.
PubMed Text format Abstract available

PEIKERT T, Duan F, Rajagopalan S, Karwoski RA, et al
Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.
PLoS One. 2018;13:e0196910.
PubMed Text format Abstract available

TARIQ H, Eldridge E, Welch I
An efficient approach for feature construction of high-dimensional microarray data by random projections.
PLoS One. 2018;13:e0196385.
PubMed Text format Abstract available

FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
PLoS One. 2018;13:e0196892.
PubMed Text format Abstract available

JAFARINEZHAD A, YektaKooshali MH
Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
PLoS One. 2018;13:e0202360.
PubMed Text format Abstract available

CHEN X, Yang Y, Katz SI
Dexamethasone pretreatment impairs the thymidylate synthase inhibition mediated flare in thymidine salvage pathway activity in non-small cell lung cancer.
PLoS One. 2018;13:e0202384.
PubMed Text format Abstract available

YANO Y, Kurebe H, Edahiro R, Hosono Y, et al
Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study.
PLoS One. 2018;13:e0203070.
PubMed Text format Abstract available

LEE DH, Tsao MS, Kambartel KO, Isobe H, et al
Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study.
PLoS One. 2018;13:e0202865.
PubMed Text format Abstract available

SCHAD F, Thronicke A, Steele ML, Merkle A, et al
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis.
PLoS One. 2018;13:e0203058.
PubMed Text format Abstract available

CONSONNI D, Carugno M, De Matteis S, Nordio F, et al
Outdoor particulate matter (PM10) exposure and lung cancer risk in the EAGLE study.
PLoS One. 2018;13:e0203539.
PubMed Text format Abstract available

ZABLOCKA-SLOWINSKA K, Placzkowska S, Prescha A, Pawelczyk K, et al
Systemic redox status in lung cancer patients is related to altered glucose metabolism.
PLoS One. 2018;13:e0204173.
PubMed Text format Abstract available

HUANG FF, Yang Q, Zhang J, Han XY, et al
The structural equation model on self-efficacy during post-op rehabilitation among non-small cell lung cancer patients.
PLoS One. 2018;13:e0204213.
PubMed Text format Abstract available

AN BC, Choi YD, Oh IJ, Kim JH, et al
GPx3-mediated redox signaling arrests the cell cycle and acts as a tumor suppressor in lung cancer cell lines.
PLoS One. 2018;13:e0204170.
PubMed Text format Abstract available

LIN PY, Chang YJ, Chen YC, Lin CH, et al
Anti-cancer effects of 3,5-dimethylaminophenol in A549 lung cancer cells.
PLoS One. 2018;13:e0205249.
PubMed Text format Abstract available

SCHERNBERG A, Mezquita L, Boros A, Botticella A, et al
Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer.
PLoS One. 2018;13:e0204490.
PubMed Text format Abstract available

OWENS CA, Peterson CB, Tang C, Koay EJ, et al
Lung tumor segmentation methods: Impact on the uncertainty of radiomics features for non-small cell lung cancer.
PLoS One. 2018;13:e0205003.
PubMed Text format Abstract available

YAMAMOTO T, Kadoya N, Morishita Y, Sato Y, et al
Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
PLoS One. 2018;13:e0204734.
PubMed Text format Abstract available

WANG J, Duan Y, Meng QH, Gong R, et al
Integrated analysis of DNA methylation profiling and gene expression profiling identifies novel markers in lung cancer in Xuanwei, China.
PLoS One. 2018;13:e0203155.
PubMed Text format Abstract available

DUPONT G, Flory L, Morel J, Lukaszewicz AC, et al
Postoperative lymphopenia: An independent risk factor for postoperative pneumonia after lung cancer surgery, results of a case-control study.
PLoS One. 2018;13:e0205237.
PubMed Text format Abstract available

LASITHIOTAKI I, Tsitoura E, Samara KD, Trachalaki A, et al
NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer.
PLoS One. 2018;13:e0205242.
PubMed Text format Abstract available

KHUNGER M, Patil PD, Khunger A, Li M, et al
Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients.
PLoS One. 2018;13:e0197743.
PubMed Text format Abstract available

HART GR, Roffman DA, Decker R, Deng J, et al
A multi-parameterized artificial neural network for lung cancer risk prediction.
PLoS One. 2018;13:e0205264.
PubMed Text format Abstract available

LU S, Yu Y, Fu S, Ren H, et al
Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China.
PLoS One. 2018;13:e0205827.
PubMed Text format Abstract available

FU JY, Wan YL, Huang TY, Wu CF, et al
Correlation between image characteristics and pathologic findings in non small cell lung cancer patients after anatomic resection.
PLoS One. 2018;13:e0206386.
PubMed Text format Abstract available

GEZELIUS E, Flou Kristensen A, Bendahl PO, Hisada Y, et al
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
PLoS One. 2018;13:e0207387.
PubMed Text format Abstract available

JONES RA, Franks SE, Moorehead RA
Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer.
PLoS One. 2018;13:e0206948.
PubMed Text format Abstract available

ASHTON JR, Gottlin EB, Patz EF Jr, West JL, et al
A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
PLoS One. 2018;13:e0206950.
PubMed Text format Abstract available

VELCHETI V, Patwardhan PD, Liu FX, Chen X, et al
Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States.
PLoS One. 2018;13:e0206370.
PubMed Text format Abstract available

RAMELLA S, Fiore M, Greco C, Cordelli E, et al
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients.
PLoS One. 2018;13:e0207455.
PubMed Text format Abstract available

OKOLI GN, Kostopoulou O, Delaney BC
Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice.
PLoS One. 2018;13:e0207686.
PubMed Text format Abstract available

PEREZ-MORALES J, Mejias-Morales D, Rivera-Rivera S, Gonzalez-Flores J, et al
Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.
PLoS One. 2018;13:e0207483.
PubMed Text format Abstract available

GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
PLoS One. 2018;13:e0198143.
PubMed Text format Abstract available

LIM JH, Ryu JS, Kim JH, Kim HJ, et al
Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching.
PLoS One. 2018;13:e0208492.
PubMed Text format Abstract available

NAKAJIMA EC, Frankland MP, Johnson TF, Antic SL, et al
Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.
PLoS One. 2018;13:e0198118.
PubMed Text format Abstract available

ILYINSKII PO, Kovalev GI, O'Neil CP, Roy CJ, et al
Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
PLoS One. 2018;13:e0197694.
PubMed Text format Abstract available

THOMENIUS MJ, Totman J, Harvey D, Mitchell LH, et al
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
PLoS One. 2018;13:e0197372.
PubMed Text format Abstract available

PUJOL JL, Roch B, Roth C, Merel JP, et al
Qualitative study of patients' decision-making when accepting second-line treatment after failure of first-line chemotherapy.
PLoS One. 2018;13:e0197605.
PubMed Text format Abstract available

CHEN, Luo L, Liang C
Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
PLoS One. 2018;13:e0197402.
PubMed Text format Abstract available

HU ZG, Li WX, Ruan YS, Zeng FJ, et al
Incidence trends and risk prediction nomogram of metachronous second primary lung cancer in lung cancer survivors.
PLoS One. 2018;13:e0209002.
PubMed Text format Abstract available

Correction: Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice.
PLoS One. 2018;13:e0210108.
PubMed Text format Abstract available

LIU T, Chen Z, Dang J, Li G, et al
The role of surgery in stage I to III small cell lung cancer: A systematic review and meta-analysis.
PLoS One. 2018;13:e0210001.
PubMed Text format Abstract available

YANG B, Jhun BW, Shin SH, Jeong BH, et al
Comparison of four models predicting the malignancy of pulmonary nodules: A single-center study of Korean adults.
PLoS One. 2018;13:e0201242.
PubMed Text format Abstract available

PETRELLI F, Lazzari C, Ardito R, Borgonovo K, et al
Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studies.
PLoS One. 2018;13:e0201425.
PubMed Text format Abstract available

WONG ML, Shi Y, Fung KZ, Ngo S, et al
Age, comorbidity, life expectancy, and pulmonary nodule follow-up in older veterans.
PLoS One. 2018;13:e0200496.
PubMed Text format Abstract available

BALERMPAS P, Stera S, Muller von der Grun J, Loutfi-Krauss B, et al
Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
PLoS One. 2018;13:e0198692.
PubMed Text format Abstract available

MESALLES-NARANJO O, Grant I, Wyper GMA, Stockton D, et al
Trends and inequalities in the burden of mortality in Scotland 2000-2015.
PLoS One. 2018;13:e0196906.
PubMed Text format Abstract available

BOSSCHIETER J, Bach S, Bijnsdorp IV, Segerink LI, et al
A protocol for urine collection and storage prior to DNA methylation analysis.
PLoS One. 2018;13:e0200906.
PubMed Text format Abstract available

CHEN J
The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
PLoS One. 2018;13:e0200909.
PubMed Text format Abstract available

RATH EM, Cheng YY, Pinese M, Sarun KH, et al
BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state.
PLoS One. 2018;13:e0203003.
PubMed Text format Abstract available

FUKUOKA M, Yoshioka K, Hohjoh H
NF-kappaB activation is an early event of changes in gene regulation for acquiring drug resistance in human adenocarcinoma PC-9 cells.
PLoS One. 2018;13:e0201796.
PubMed Text format Abstract available

HSU JC, Lin JY, Hsu MY, Lin PC, et al
Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan.
PLoS One. 2018;13:e0202725.
PubMed Text format Abstract available

WATANABE K, Yasumoto A, Amano Y, Kage H, et al
Mean platelet volume and lymphocyte-to-monocyte ratio are associated with shorter progression-free survival in EGFR-mutant lung adenocarcinoma treated by EGFR tyrosine kinase inhibitor.
PLoS One. 2018;13:e0203625.
PubMed Text format Abstract available

OTSUKA M, Monzen H, Matsumoto K, Tamura M, et al
Evaluation of lung toxicity risk with computed tomography ventilation image for thoracic cancer patients.
PLoS One. 2018;13:e0204721.
PubMed Text format Abstract available

LEE JH, Kim TH, Lee S, Han K, et al
High versus low attenuation thresholds to determine the solid component of ground-glass opacity nodules.
PLoS One. 2018;13:e0205490.
PubMed Text format Abstract available

ZABECK H, Dienemann H, Hoffmann H, Pfannschmidt J, et al
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.
PLoS One. 2018;13:e0206132.
PubMed Text format Abstract available

NAKANO H, Kawahara D, Ono K, Akagi Y, et al
Effect of dose-delivery time for flattened and flattening filter-free photon beams based on microdosimetric kinetic model.
PLoS One. 2018;13:e0206673.
PubMed Text format Abstract available

DOU TH, Coroller TP, van Griethuysen JJM, Mak RH, et al
Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
PLoS One. 2018;13:e0206108.
PubMed Text format Abstract available

DOMPE N, Klijn C, Watson SA, Leng K, et al
A CRISPR screen identifies MAPK7 as a target for combination with MEK inhibition in KRAS mutant NSCLC.
PLoS One. 2018;13:e0199264.
PubMed Text format Abstract available

HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
PLoS One. 2018;13:e0208573.
PubMed Text format Abstract available

January 2017

RYUGE S, Sato Y, Nagashio R, Hiyoshi Y, et al
Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
PLoS One. 2017;12:e0173886.
PubMed Text format Abstract available

HOU GX, Liu P, Yang J, Wen S, et al
Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
PLoS One. 2017;12:e0174515.
PubMed Text format Abstract available

OGUMA T, Nagaoka T, Kurahashi M, Kobayashi N, et al
Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
PLoS One. 2017;12:e0174802.
PubMed Text format Abstract available

FAN L, Chen L, Ni X, Guo S, et al
Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.
PLoS One. 2017;12:e0175666.
PubMed Text format Abstract available

DAVIES J, Patel M, Gridelli C, de Marinis F, et al
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies.
PLoS One. 2017;12:e0175679.
PubMed Text format Abstract available

SHEN G, Lan Y, Zhang K, Ren P, et al
Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
PLoS One. 2017;12:e0176150.
PubMed Text format Abstract available

HE M, Yang Z, Zhang L, Song C, et al
Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells.
PLoS One. 2017;12:e0175466.
PubMed Text format Abstract available

SHIRAI K, Kawashima M, Saitoh JI, Abe T, et al
Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
PLoS One. 2017;12:e0175589.
PubMed Text format Abstract available

CAO G, Cheng D, Ye L, Pan Y, et al
Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
PLoS One. 2017;12:e0175284.
PubMed Text format Abstract available

XU Z, Yan Y, Xiao L, Dai S, et al
Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.
PLoS One. 2017;12:e0175977.
PubMed Text format Abstract available

INOUE Y, Shiihara J, Miyazawa H, Ohta H, et al
A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.
PLoS One. 2017;12:e0176525.
PubMed Text format Abstract available

FUKUDA T, Nomura M, Kato Y, Tojo H, et al
A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references.
PLoS One. 2017;12:e0176219.
PubMed Text format Abstract available

BAILEY G, Healy A, Young BD, Sharma E, et al
Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium.
PLoS One. 2017;12:e0175678.
PubMed Text format Abstract available

TAKAMOCHI K, Mogushi K, Kawaji H, Imashimizu K, et al
Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
PLoS One. 2017;12:e0175622.
PubMed Text format Abstract available

DENEKA AY, Haber L, Kopp MC, Gaponova AV, et al
Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
PLoS One. 2017;12:e0176747.
PubMed Text format Abstract available

DURDA K, Kaklewski K, Gupta S, Szydlowski M, et al
Serum folate concentration and the incidence of lung cancer.
PLoS One. 2017;12:e0177441.
PubMed Text format Abstract available

KIM JS, Cho MS, Nam JH, Kim HJ, et al
Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
PLoS One. 2017;12:e0177015.
PubMed Text format Abstract available

JUN HY, Kim TH, Choi JW, Lee YH, et al
Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging.
PLoS One. 2017;12:e0178204.
PubMed Text format Abstract available

HOLMBOE S, Hansen PL, Thisgaard H, Block I, et al
Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
PLoS One. 2017;12:e0178286.
PubMed Text format Abstract available

PARK SL, Murphy SE, Wilkens LR, Stram DO, et al
Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
PLoS One. 2017;12:e0178435.
PubMed Text format Abstract available

CAMERON SJS, Lewis KE, Huws SA, Hegarty MJ, et al
A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer.
PLoS One. 2017;12:e0177062.
PubMed Text format Abstract available

CHANG HW, Lin ZM, Wu MJ, Wang LY, et al
Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.
PLoS One. 2017;12:e0175586.
PubMed Text format Abstract available

CARRERAS-TORRES R, Johansson M, Haycock PC, Wade KH, et al
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.
PLoS One. 2017;12:e0177875.
PubMed Text format Abstract available

CHANG YP, Chen YM, Lai CH, Lin CY, et al
The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
PLoS One. 2017;12:e0178676.
PubMed Text format Abstract available

WEISS GJ, Byron SA, Aldrich J, Sangal A, et al
A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy.
PLoS One. 2017;12:e0179170.
PubMed Text format Abstract available

ABERNETHY AP, Arunachalam A, Burke T, McKay C, et al
Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
PLoS One. 2017;12:e0178420.
PubMed Text format Abstract available

WU YT, Li X, Liu ZL, Xu Z, et al
Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
PLoS One. 2017;12:e0179680.
PubMed Text format Abstract available

YAGI S, Koh Y, Akamatsu H, Kanai K, et al
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
PLoS One. 2017;12:e0179744.
PubMed Text format Abstract available

BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
Correction: Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
PLoS One. 2017;12:e0179803.
PubMed Text format Abstract available

SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
PLoS One. 2017;12:e0177146.
PubMed Text format Abstract available

LOISELLE JJ, Roy JG, Sutherland LC
RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
PLoS One. 2017;12:e0180258.
PubMed Text format Abstract available

DE MARCO C, Laudanna C, Rinaldo N, Oliveira DM, et al
Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
PLoS One. 2017;12:e0178865.
PubMed Text format Abstract available

LEE AF, Chen MC, Chen CJ, Yang CJ, et al
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
PLoS One. 2017;12:e0180383.
PubMed Text format Abstract available

GUISIER F, Bohn P, Patout M, Piton N, et al
In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy.
PLoS One. 2017;12:e0180576.
PubMed Text format Abstract available

POWELL AC, Mirhadi AJ, Loy BA, Happe LE, et al
Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer.
PLoS One. 2017;12:e0181319.
PubMed Text format Abstract available

GOTO A, Tanaka M, Yoshida M, Umakoshi M, et al
The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
PLoS One. 2017;12:e0181270.
PubMed Text format Abstract available

SAUSVILLE LN, Jones CC, Aldrich MC, Blot WJ, et al
Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.
PLoS One. 2017;12:e0180471.
PubMed Text format Abstract available

LIU PL, Liu WL, Chang JM, Chen YH, et al
MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
PLoS One. 2017;12:e0180844.
PubMed Text format Abstract available

MESSARITAKIS I, Politaki E, Kotsakis A, Dermitzaki EK, et al
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
PLoS One. 2017;12:e0181211.
PubMed Text format Abstract available

SILVA EM, Mariano VS, Pastrez PRA, Pinto MC, et al
High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
PLoS One. 2017;12:e0181125.
PubMed Text format Abstract available

TANG ZM, Ling ZG, Wang CM, Wu YB, et al
Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
PLoS One. 2017;12:e0182117.
PubMed Text format Abstract available

BANJARA M, Ghosh C, Dadas A, Mazzone P, et al
Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients.
PLoS One. 2017;12:e0181409.
PubMed Text format Abstract available

SARIN N, Engel F, Kalayda GV, Mannewitz M, et al
Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
PLoS One. 2017;12:e0181081.
PubMed Text format Abstract available

PATNAIK SK, Kannisto ED, Mallick R, Vachani A, et al
Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
PLoS One. 2017;12:e0181926.
PubMed Text format Abstract available

AL-SAAD S, Richardsen E, Kilvaer TK, Donnem T, et al
The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
PLoS One. 2017;12:e0181527.
PubMed Text format Abstract available

OH TK, Jeon JH, Lee JM, Kim MS, et al
Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery.
PLoS One. 2017;12:e0181672.
PubMed Text format Abstract available

KOLEK V, Grygarkova I, Koubkova L, Skrickova J, et al
Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up.
PLoS One. 2017;12:e0181803.
PubMed Text format Abstract available

GONG X, Liu J, Zhang D, Yang D, et al
GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
PLoS One. 2017;12:e0182410.
PubMed Text format Abstract available

LIU L, He Y, Ge G, Li L, et al
Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
PLoS One. 2017;12:e0182168.
PubMed Text format Abstract available

PELAEZ R, Morales X, Salvo E, Garasa S, et al
beta3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
PLoS One. 2017;12:e0181579.
PubMed Text format Abstract available

MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
PLoS One. 2017;12:e0181564.
PubMed Text format Abstract available

TONG M, Wang J, Jiang N, Pan H, et al
Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
PLoS One. 2017;12:e0182282.
PubMed Text format Abstract available

SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
PLoS One. 2017;12:e0183201.
PubMed Text format Abstract available

CHEN B, Yang L, Zhang R, Gan Y, et al
Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
PLoS One. 2017;12:e0182891.
PubMed Text format Abstract available

CHENG CC, Chang J, Huang SC, Lin HC, et al
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
PLoS One. 2017;12:e0182149.
PubMed Text format Abstract available

NAKANO T, Kanai Y, Amano Y, Yoshimoto T, et al
Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
PLoS One. 2017;12:e0181342.
PubMed Text format Abstract available

PILYUGIN M, Descloux P, Andre PA, Laszlo V, et al
BARD1 serum autoantibodies for the detection of lung cancer.
PLoS One. 2017;12:e0182356.
PubMed Text format Abstract available

KIM EK, Kim KA, Lee CY, Shim HS, et al
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
PLoS One. 2017;12:e0171280.
PubMed Text format Abstract available

WANICHTHANARAK K, Fan S, Grapov D, Barupal DK, et al
Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration.
PLoS One. 2017;12:e0171046.
PubMed Text format Abstract available

ORTIZ-ZAPATER E, Lee RW, Owen W, Weitsman G, et al
MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.
PLoS One. 2017;12:e0170798.
PubMed Text format Abstract available

HARATI S, Cooper LA, Moran JD, Giuste FO, et al
MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
PLoS One. 2017;12:e0170339.
PubMed Text format Abstract available

FANG Y, Zhang C, Wu T, Wang Q, et al
Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells.
PLoS One. 2017;12:e0170609.
PubMed Text format Abstract available

NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
PLoS One. 2017;12:e0170054.
PubMed Text format Abstract available

KISELEVA R, Greineder CF, Villa CH, Hood ED, et al
Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
PLoS One. 2017;12:e0169537.
PubMed Text format Abstract available

ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
PLoS One. 2017;12:e0169875.
PubMed Text format Abstract available

CHOUAID C, Debieuvre D, Durand-Zaleski I, Fernandes J, et al
Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
PLoS One. 2017;12:e0182798.
PubMed Text format Abstract available

SHIN J, Song SY, Ahn HS, An BC, et al
Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
PLoS One. 2017;12:e0183896.
PubMed Text format Abstract available

JOVELET C, Madic J, Remon J, Honore A, et al
Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer.
PLoS One. 2017;12:e0183319.
PubMed Text format Abstract available

CHEN L, Lu J, Huang T, Cai YD, et al
A computational method for the identification of candidate drugs for non-small cell lung cancer.
PLoS One. 2017;12:e0183411.
PubMed Text format Abstract available

YANG JH, Li XY, Wang X, Hou WJ, et al
Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
PLoS One. 2017;12:e0182775.
PubMed Text format Abstract available

KONG GM, Yu M, Gu Z, Chen Z, et al
Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.
PLoS One. 2017;12:e0181601.
PubMed Text format Abstract available

ZHANG C, Wei B, Li P, Yang K, et al
Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
PLoS One. 2017;12:e0173524.
PubMed Text format Abstract available

WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
PLoS One. 2017;12:e0173933.
PubMed Text format Abstract available

ASOR E, Stav MY, Simon E, Fahoum I, et al
Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
PLoS One. 2017;12:e0173760.
PubMed Text format Abstract available

ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
PLoS One. 2017;12:e0172788.
PubMed Text format Abstract available

PUNIA R, Raina K, Agarwal R, Singh RP, et al
Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.
PLoS One. 2017;12:e0182870.
PubMed Text format Abstract available

VAN DER WEKKEN AJ, Kuiper JL, Saber A, Terpstra MM, et al
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
PLoS One. 2017;12:e0182885.
PubMed Text format Abstract available

HSU MK, Lin HY, Chen FC
NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events.
PLoS One. 2017;12:e0174798.
PubMed Text format Abstract available

PARK JE, Chun SE, Reichel D, Min JS, et al
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
PLoS One. 2017;12:e0173247.
PubMed Text format Abstract available

JIN J, Hu K, Zhou Y, Li W, et al
Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
PLoS One. 2017;12:e0184412.
PubMed Text format Abstract available

CAO X, MacNaughton P, Laurent JC, Allen JG, et al
Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies.
PLoS One. 2017;12:e0184298.
PubMed Text format Abstract available

DE BIASE D, Genestreti G, Visani M, Acquaviva G, et al
The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
PLoS One. 2017;12:e0177822.
PubMed Text format Abstract available

HSIEH CC, Sun YH, Lin SW, Yeh YC, et al
Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases.
PLoS One. 2017;12:e0176918.
PubMed Text format Abstract available

LEE DH, Hwang SH, Lim MK, Oh JK, et al
Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
PLoS One. 2017;12:e0176783.
PubMed Text format Abstract available

CAI G, Xiao F, Cheng C, Li Y, et al
Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.
PLoS One. 2017;12:e0175850.
PubMed Text format Abstract available

AGRAWAL V, Coroller TP, Hou Y, Lee SW, et al
Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.
PLoS One. 2017;12:e0174268.
PubMed Text format Abstract available

LYNCH CM, van Berkel VH, Frieboes HB
Application of unsupervised analysis techniques to lung cancer patient data.
PLoS One. 2017;12:e0184370.
PubMed Text format Abstract available

CAI NL, Lau ATY, Yu FY, Wu DD, et al
Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.
PLoS One. 2017;12:e0184755.
PubMed Text format Abstract available

SHEN Z, Wang H, Xi W, Deng X, et al
Multi-phase simultaneous segmentation of tumor in lung 4D-CT data with context information.
PLoS One. 2017;12:e0178411.
PubMed Text format Abstract available

KOO HJ, Kim MY, Koo JH, Sung YS, et al
Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation.
PLoS One. 2017;12:e0177379.
PubMed Text format Abstract available

ZHAO XK, Mao YM, Meng H, Song X, et al
Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
PLoS One. 2017;12:e0177504.
PubMed Text format Abstract available

FARQUHAR M, Penfold C, Benson J, Lovick R, et al
Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.
PLoS One. 2017;12:e0177081.
PubMed Text format Abstract available

WANG XF, Zhu YT, Wang JJ, Zeng DX, et al
The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
PLoS One. 2017;12:e0185168.
PubMed Text format Abstract available

ELLSWORTH SG, Rabatic BM, Chen J, Zhao J, et al
Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy.
PLoS One. 2017;12:e0183239.
PubMed Text format Abstract available

WANG C, Zhang X, Li H, Li X, et al
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
PLoS One. 2017;12:e0179664.
PubMed Text format Abstract available

WANG L, Tang C, Xu B, Yang L, et al
Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
PLoS One. 2017;12:e0179000.
PubMed Text format Abstract available

YIP SSF, Parmar C, Blezek D, Estepar RSJ, et al
Application of the 3D slicer chest imaging platform segmentation algorithm for large lung nodule delineation.
PLoS One. 2017;12:e0178944.
PubMed Text format Abstract available

KEARNEY P, Hunsucker SW, Li XJ, Porter A, et al
An integrated risk predictor for pulmonary nodules.
PLoS One. 2017;12:e0177635.
PubMed Text format Abstract available

KEE JY, Han YH, Kim DS, Mun JG, et al
beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.
PLoS One. 2017;12:e0176937.
PubMed Text format Abstract available

WANG T, Moon JY, Wu Y, Amos CI, et al
Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium.
PLoS One. 2017;12:e0185660.
PubMed Text format Abstract available

SHAN S, She J, Xue ZQ, Su CX, et al
Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.
PLoS One. 2017;12:e0185485.
PubMed Text format Abstract available

WANG F, Xu X, Yang J, Min L, et al
Height and lung cancer risk: A meta-analysis of observational studies.
PLoS One. 2017;12:e0185316.
PubMed Text format Abstract available

CIRCU M, Cardelli J, Barr M, O'Byrne K, et al
Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
PLoS One. 2017;12:e0184922.
PubMed Text format Abstract available

NOWICKI-OSUCH K, Li Y, Challinor M, Gerrard DT, et al
EINCR1 is an EGF inducible lincRNA overexpressed in lung adenocarcinomas.
PLoS One. 2017;12:e0181902.
PubMed Text format Abstract available

PIRIE-SHEPHERD SR, Painter C, Whalen P, Vizcarra P, et al
Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients.
PLoS One. 2017;12:e0179561.
PubMed Text format Abstract available

TAKADA K, Okamoto T, Tominaga M, Teraishi K, et al
Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.
PLoS One. 2017;12:e0181598.
PubMed Text format Abstract available

CHOI BH, Young HS, Quan YH, Rho J, et al
Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit.
PLoS One. 2017;12:e0179220.
PubMed Text format Abstract available

LENDECKEL D, Kromrey ML, Ittermann T, Schafer S, et al
Pulmonary emphysema is a predictor of pneumothorax after CT-guided transthoracic pulmonary biopsies of pulmonary nodules.
PLoS One. 2017;12:e0178078.
PubMed Text format Abstract available

MINCHOM A, Thavasu P, Ahmad Z, Stewart A, et al
A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
PLoS One. 2017;12:e0186106.
PubMed Text format Abstract available

ILIE M, Khambata-Ford S, Copie-Bergman C, Huang L, et al
Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
PLoS One. 2017;12:e0183023.
PubMed Text format Abstract available

MUSCELLA A, Vetrugno C, Cossa LG, Antonaci G, et al
Apoptosis by [Pt(O,O'-acac)(gamma-acac)(DMS)] requires PKC-delta mediated p53 activation in malignant pleural mesothelioma.
PLoS One. 2017;12:e0181114.
PubMed Text format Abstract available

YVOREL V, Patoir A, Casteillo F, Tissot C, et al
PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
PLoS One. 2017;12:e0180346.
PubMed Text format Abstract available

BORIN TF, Shankar A, Angara K, Rashid MH, et al
HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.
PLoS One. 2017;12:e0178830.
PubMed Text format Abstract available

KASPI E, Frankel D, Guinde J, Perrin S, et al
Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.
PLoS One. 2017;12:e0183136.
PubMed Text format Abstract available

KROSNICK JA, Malhotra N, Mo CH, Bruera EF, et al
Perceptions of health risks of cigarette smoking: A new measure reveals widespread misunderstanding.
PLoS One. 2017;12:e0182063.
PubMed Text format Abstract available

TUDOR RA, D'Silva A, Tremblay A, MacEachern P, et al
Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.
PLoS One. 2017;12:e0181867.
PubMed Text format Abstract available

JIN C, Zhang G, Zhang Y, Hua P, et al
Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells.
PLoS One. 2017;12:e0181731.
PubMed Text format Abstract available

YU PY, Gardner HL, Roberts R, Cam H, et al
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
PLoS One. 2017;12:e0181885.
PubMed Text format Abstract available

NAKAMURA S, Hayashi K, Imaoka Y, Kitamura Y, et al
Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.
PLoS One. 2017;12:e0186192.
PubMed Text format Abstract available

PEARCE A, Haas M, Viney R, Pearson SA, et al
Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
PLoS One. 2017;12:e0184360.
PubMed Text format Abstract available

D'HOOGHE JNS, Goorsenberg AWM, de Bruin DM, Roelofs JJTH, et al
Optical coherence tomography for identification and quantification of human airway wall layers.
PLoS One. 2017;12:e0184145.
PubMed Text format Abstract available

LIAO HF, Pan CH, Chou PY, Chen YF, et al
Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
PLoS One. 2017;12:e0185021.
PubMed Text format Abstract available

LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
PLoS One. 2017;12:e0183288.
PubMed Text format Abstract available

SUTTON BC, Birse RT, Maggert K, Ray T, et al
Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX(R) HS, a new highly sensitive assay for the MassARRAY(R) System.
PLoS One. 2017;12:e0183715.
PubMed Text format Abstract available

BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
PLoS One. 2017;12:e0184680.
PubMed Text format Abstract available

HUANG JY, Wang R, Gao YT, Yuan JM, et al
ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
PLoS One. 2017;12:e0184295.
PubMed Text format Abstract available

KWIECIEN JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, et al
Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
PLoS One. 2017;12:e0183883.
PubMed Text format Abstract available

FORNARO L, Vivaldi C, Lin D, Xue H, et al
Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.
PLoS One. 2017;12:e0182818.
PubMed Text format Abstract available

LI Y, Xu H, Su S, Ye J, et al
Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
PLoS One. 2017;12:e0183331.
PubMed Text format Abstract available

KWAK KM, Paek D, Hwang SS, Ju YS, et al
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.
PLoS One. 2017;12:e0183404.
PubMed Text format Abstract available

NOGUEIRA JORGE NA, Wajnberg G, Ferreira CG, de Sa Carvalho B, et al
snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.
PLoS One. 2017;12:e0183410.
PubMed Text format Abstract available

VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
PLoS One. 2017;12:e0185786.
PubMed Text format Abstract available

MOON MH, Beck KS, Moon YK, Park JK, et al
Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery.
PLoS One. 2017;12:e0185140.
PubMed Text format Abstract available

JIANG R, Dong X, Zhu W, Duan Q, et al
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
PLoS One. 2017;12:e0184338.
PubMed Text format Abstract available

KIND M, Klukowska-Rotzler J, Berezowska S, Arcaro A, et al
Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
PLoS One. 2017;12:e0187308.
PubMed Text format Abstract available

FORCELLA M, Oldani M, Epistolio S, Freguia S, et al
Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.
PLoS One. 2017;12:e0187289.
PubMed Text format Abstract available

SCHMIDT LH, Heitkotter B, Schulze AB, Schliemann C, et al
Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.
PLoS One. 2017;12:e0186280.
PubMed Text format Abstract available

OTOSHI T, Kataoka Y, Ikegaki S, Saito E, et al
Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
PLoS One. 2017;12:e0185850.
PubMed Text format Abstract available

ZHAO J, Dinkel J, Warth A, Penzel R, et al
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.
PLoS One. 2017;12:e0182741.
PubMed Text format Abstract available

LIU K, Zheng D, Xu G, Du Z, et al
Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
PLoS One. 2017;12:e0187350.
PubMed Text format Abstract available

ARNS A, Blessing M, Fleckenstein J, Stsepankou D, et al
Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer.
PLoS One. 2017;12:e0187710.
PubMed Text format Abstract available

CHEN YF, Yuan A, Cho KH, Lu YC, et al
Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
PLoS One. 2017;12:e0187824.
PubMed Text format Abstract available

JABS V, Edlund K, Konig H, Grinberg M, et al
Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
PLoS One. 2017;12:e0187246.
PubMed Text format Abstract available

FRENZEL T, Hoffmann B, Schmitz R, Bethge A, et al
Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.
PLoS One. 2017;12:e0187144.
PubMed Text format Abstract available

SEO SR, Lee HM, Choi HS, Kim WT, et al
Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells.
PLoS One. 2017;12:e0188075.
PubMed Text format Abstract available

SIKDAR S, Datta S, Datta S
EAMA: Empirically adjusted meta-analysis for large-scale simultaneous hypothesis testing in genomic experiments.
PLoS One. 2017;12:e0187287.
PubMed Text format Abstract available

LIN CY, Wu YM, Hsieh MH, Wang CW, et al
Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
PLoS One. 2017;12:e0186567.
PubMed Text format Abstract available

JIAO DM, Yan L, Wang LS, Hu HZ, et al
Retraction: Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
PLoS One. 2017;12:e0189070.
PubMed Text format

LIU B, Zhao Y, Yuan J, Zeng L, et al
Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.
PLoS One. 2017;12:e0187860.
PubMed Text format Abstract available

VAN RIEL SJ, Ciompi F, Winkler Wille MM, Dirksen A, et al
Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
PLoS One. 2017;12:e0185032.
PubMed Text format Abstract available

LI R, Zhang Y, Yuan Y, Lin Q, et al
Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
PLoS One. 2017;12:e0187390.
PubMed Text format Abstract available

ZHOU S, Wang P, Su X, Chen J, et al
High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
PLoS One. 2017;12:e0187356.
PubMed Text format Abstract available

MARCOS-VADILLO E, Garcia-Sanchez A, Sanz C, Davila I, et al
PTGDR gene expression and response to dexamethasone treatment in an in vitro model.
PLoS One. 2017;12:e0186957.
PubMed Text format Abstract available

ISAKSSON S, Jonsson P, Monsef N, Brunnstrom H, et al
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.
PLoS One. 2017;12:e0186284.
PubMed Text format Abstract available

BRINKHOF S, Groen HJM, Siesling SS, IJzerman MJ, et al
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences.
PLoS One. 2017;12:e0189251.
PubMed Text format Abstract available

KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
PLoS One. 2017;12:e0189410.
PubMed Text format Abstract available

ZHANG H, Diao H, Jia L, Yuan Y, et al
Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
PLoS One. 2017;12:e0188960.
PubMed Text format Abstract available

OOI CC, Mantalas GL, Koh W, Neff NF, et al
High-throughput full-length single-cell mRNA-seq of rare cells.
PLoS One. 2017;12:e0188510.
PubMed Text format Abstract available

KANG G, Liu K, Hou B, Zhang N, et al
3D multi-view convolutional neural networks for lung nodule classification.
PLoS One. 2017;12:e0188290.
PubMed Text format Abstract available

HAN KN, Kim HK, Choi YH
Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection.
PLoS One. 2017;12:e0186857.
PubMed Text format Abstract available

KIM H, Park CM, Keam B, Park SJ, et al
The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.
PLoS One. 2017;12:e0187500.
PubMed Text format Abstract available

GALLARDO-ESTRELLA L, Pompe E, de Jong PA, Jacobs C, et al
Normalized emphysema scores on low dose CT: Validation as an imaging biomarker for mortality.
PLoS One. 2017;12:e0188902.
PubMed Text format Abstract available

TAKAHASHI Y, Yasui T, Tamari K, Minami K, et al
Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
PLoS One. 2017;12:e0189697.
PubMed Text format Abstract available

SABIR SH, Krishnamurthy S, Gupta S, Mills GB, et al
Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.
PLoS One. 2017;12:e0189651.
PubMed Text format Abstract available

January 2016

GOK DURNALI A, Paksoy Turkoz F, Ardic Yukruk F, Tokluoglu S, et al
Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
PLoS One. 2016;11:e0152621.
PubMed Text format Abstract available

ZHANG L, Qian H, Sha M, Luan Z, et al
Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
PLoS One. 2016;11:e0164838.
PubMed Text format Abstract available

FORGACS A, Pall Jonsson H, Dahlbom M, Daver F, et al
A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.
PLoS One. 2016;11:e0164113.
PubMed Text format Abstract available

ZHANG L, Wang L, Tian P, Tian S, et al
Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
PLoS One. 2016;11:e0165543.
PubMed Text format Abstract available

APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
PLoS One. 2016;11:e0155262.
PubMed Text format Abstract available

SCHUSTER C, Akslen LA, Straume O
Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
PLoS One. 2016;11:e0155242.
PubMed Text format Abstract available

SLADE RL, Pisaneschi F, Nguyen QD, Smith G, et al
Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography.
PLoS One. 2016;11:e0161427.
PubMed Text format Abstract available

WANG D, Zhang M, Gao X, Yu L, et al
Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
PLoS One. 2016;11:e0158307.
PubMed Text format Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: